Claim Missing Document
Check
Articles

Found 30 Documents
Search

Compulsive Sexual Behavior as a Maladaptive Coping Mechanism in Bipolar Affective Disorder: A Case Report Shafly, Moch Syafirul Nur; Ahadiah, Hayyunah Rohmatul; Syadza, Lailatus; Algristian, Hafid; Setyorini, Dian
Sinergi International Journal of Psychology Vol. 3 No. 3 (2025): August 2025
Publisher : Yayasan Sinergi Kawula Muda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61194/psychology.v3i3.785

Abstract

Compulsive Sexual Behavior (CSB) is increasingly acknowledged as a comorbid feature in individuals with Bipolar Affective Disorder (BAD), particularly during manic episodes. It often presents as a maladaptive coping mechanism for affective instability and unresolved trauma. This case report describes a 31-year-old male diagnosed with BAD and exhibiting chronic compulsive pornography use, social withdrawal, and dependent personality traits. The patient’s compulsive behavior persisted beyond mood episodes and was characterized by a persistent inability to control sexual urges, leading to distress and impaired daily functioning. Developmental history revealed early exposure to family conflict, emotional neglect, and an overdependent relationship with his mother, which contributed to insecure attachment and limited autonomy. The patient used pornography as an emotional escape, particularly during episodes of anxiety, loneliness, or boredom. Psychiatric evaluation confirmed comorbidity with Compulsive Sexual Behavior Disorder (CSBD) based on ICD-11 criteria. Therapeutic intervention included Cognitive Behavioral Therapy (CBT) tailored to address compulsive behavior, emotion regulation deficits, and trauma-related triggers. The patient responded favorably to structured psychoeducation and behavioral strategies, although long-term outcomes remain uncertain due to limited follow-up. This case underscores the complex interplay between CSB and BAD, with implications for diagnosis, treatment planning, and long-term management. It highlights the importance of early recognition of CSB symptoms, the role of trauma-informed care, and the need for integrative therapeutic approaches in patients with dual diagnoses. Clinicians are encouraged to assess compulsive behaviors beyond the scope of mood symptoms and address them as independent therapeutic targets to enhance functional recovery.
Lavender Essential Oil as an Adjuvant Therapy for Anxiety Disorders Chambali, Zafira Aliya Shafwa Putri; Algristian, Hafid
Journal of Health Literacy and Qualitative Research Vol. 5 No. 2 (2025): September 2025
Publisher : Yayasan Sinergi Kawula Muda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61194/jhlqr.v5i2.781

Abstract

With more than 301 million sufferers worldwide, anxiety disorders have become one of the most widespread mental health difficulties that frequently seek accessible and effective treatment alternatives. Anxiety results from the brain's response to a stimulus or perceived threat that a person will attempt to avoid. The limitless potential of lavender essential oil (Lavandula angustifolia) as an adjuvant therapy for anxiety disorders is investigated in this study, emphasizing the anxiolytic qualities and mechanisms of action of the oil. Data were collected from electronic sources like PubMed, Google Scholar, and Scopus, using a literature review methodology after a thorough literature search, emphasizing studies released in the previous ten years. The results suggest that lavender essential oil regulates the limbic system, especially the amygdala, as a central emotional response. It targets GABA activity and affects monoamine neurotransmitters, mainly through its active components, linalool and linalyl acetate. The most efficient method of delivery was inhalation, which considerably reduced anxiety symptoms with minimum side effects. According to the study, lavender essential oil shows promise as a complementary therapy for anxiety, providing a safe, all-natural substitute for treating anxiety.
Lavender Essential Oils (LEO) as Adjunctive Therapy for Cognitive Disorders: A Study of Dopaminergic and Olfactory Pathways Hermanto, Syalsabila Yumnaningtyas; Algristian, Hafid
Journal of Health Literacy and Qualitative Research Vol. 5 No. 2 (2025): September 2025
Publisher : Yayasan Sinergi Kawula Muda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61194/jhlqr.v5i2.783

Abstract

Cognitive impairment is a hallmark of several psychiatric disorders, including depression and schizophrenia, and is frequently associated with disruptions in dopaminergic signaling and neuroplasticity. These cognitive deficits, affecting attention, memory, and executive functions, often persist despite pharmacological treatment. Emerging evidence suggests that non-pharmacological interventions, such as aromatherapy, may offer novel pathways to enhance cognitive function. This systematic review investigates the therapeutic potential of Lavender Essential Oil (LEO) as an adjunctive treatment, focusing on its capacity to modulate dopaminergic transmission and stimulate olfactory pathways. LEO contains bioactive compounds primarily linalool and linalyl acetate which have demonstrated neuroprotective, anti-inflammatory, and neuromodulatory effects. Through interaction with the ERK/MAPK signaling cascade and upregulation of brain-derived neurotrophic factor (BDNF), LEO enhances synaptogenesis and neuroplasticity. Additionally, olfactory stimulation by LEO promotes increased alpha and theta brainwave activity, which is associated with improved focus and memory encoding. The reviewed studies highlight both preclinical and clinical evidence supporting LEO’s role in cognitive restoration. However, while promising, further high-quality clinical trials are needed to determine standardized dosages, delivery methods, and long-term safety. Integrating LEO into multimodal cognitive therapy frameworks may present a compelling complement to conventional treatments, particularly for patients with treatment-resistant cognitive symptoms.Cognitive impairment is a hallmark of several psychiatric disorders, including depression and schizophrenia, and is frequently associated with disruptions in dopaminergic signaling and neuroplasticity. These cognitive deficits, affecting attention, memory, and executive functions, often persist despite pharmacological treatment. Emerging evidence suggests that non-pharmacological interventions, such as aromatherapy, may offer novel pathways to enhance cognitive function. This systematic review investigates the therapeutic potential of Lavender Essential Oil (LEO) as an adjunctive treatment, focusing on its capacity to modulate dopaminergic transmission and stimulate olfactory pathways. LEO contains bioactive compounds primarily linalool and linalyl acetate which have demonstrated neuroprotective, anti-inflammatory, and neuromodulatory effects. Through interaction with the ERK/MAPK signaling cascade and upregulation of brain-derived neurotrophic factor (BDNF), LEO enhances synaptogenesis and neuroplasticity. Additionally, olfactory stimulation by LEO promotes increased alpha and theta brainwave activity, which is associated with improved focus and memory encoding. The reviewed studies highlight both preclinical and clinical evidence supporting LEO’s role in cognitive restoration. However, while promising, further high-quality clinical trials are needed to determine standardized dosages, delivery methods, and long-term safety. Integrating LEO into multimodal cognitive therapy frameworks may present a compelling complement to conventional treatments, particularly for patients with treatment-resistant cognitive symptoms.
Lavender Essential Oil as an Adjuvant Therapy for Anti-Depression Brylyani, Diyani Shafira; Algristian, Hafid
Journal of Health Literacy and Qualitative Research Vol. 5 No. 2 (2025): September 2025
Publisher : Yayasan Sinergi Kawula Muda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61194/jhlqr.v5i2.786

Abstract

This study aims to examine the potential of lavender essential oil as an adjuvant therapy for anti-depression by analyzing its effects on mental well-being. The method used is a systematic literature review, focusing on clinical and experimental studies that investigate the impact of lavender essential oil on depressive symptoms. The literature review explores its pharmacological properties, including its influence on neurotransmitters and stress-related biomarkers. The results indicate that lavender essential oil demonstrates anxiolytic and antidepressant effects, potentially enhancing conventional treatments. However, further clinical trials are needed to establish standardized dosages and mechanisms.
The Role of Lavender Essential Oils (LEO) in Managing Stress and Neuroinflammation: An Immunopsychiatric Perspective Kamila, Putri Faradisa; Algristian, Hafid
Jurnal Riset Kualitatif dan Promosi Kesehatan Vol. 4 No. 2 (2025): July 2025
Publisher : Yayasan Sinergi Kawula Muda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61194/jrkpk.v4i2.787

Abstract

Lavender essential oil (LEO) has gained significant attention for its potential role in managing stress and neuroinflammation, offering a promising avenue in immunopsychiatry. Rich in bioactive compounds such as linalool and linalyl acetate, LEO exhibits anxiolytic, anti- inflammatory, and neuroprotective properties. Emerging evidence suggests that LEO modulates the hypothalamic-pituitary-adrenal (HPA) axis, reduces cortisol levels, and influences neurotransmitter pathways, thereby alleviating stress-related symptoms. Furthermore, its anti- inflammatory effects contribute to mitigating neuroinflammation, a key factor in mood disorders such as depression and anxiety. This review explores the immunopsychiatric mechanisms underlying LEO’s therapeutic potential, highlighting its role as a complementary intervention in stress-related neuropsychiatric conditions.
The Effect of Aromatherapy Lavender Essential Oils on the Quality of Life of Patients with Chronic Diseases and Pain Aldi, Danya Rania; Algristian, Hafid
Jurnal Riset Kualitatif dan Promosi Kesehatan Vol. 4 No. 2 (2025): July 2025
Publisher : Yayasan Sinergi Kawula Muda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61194/jrkpk.v4i2.788

Abstract

This study aims to examine the therapeutic benefits of lavender essential oil (LEO) on pain management and its potential to improve the quality of life in patients with chronic diseases. Chronic pain is a common and incapacitating illness that profoundly affects physical and mental health, leading to increased interest in complementary and alternative therapy. Lavender essential oil, recognized for its soothing aroma and therapeutic benefits, has garnered interest for its analgesic, anxiolytic, and anti-inflammatory characteristics. These advantages are thought to be facilitated by several physiological processes, including the regulation of transient receptor potential (TRP) channels, which are involved in sensory perception and pain signalling. This study utilizes a systematic literature review technique, concentrating on both clinical and experimental studies to investigate the effectiveness of lavender essential oil in alleviating pain. The analysis includes many chronic illnesses such as neuropathic pain, arthritis, cancer-related pain, and fibromyalgia. The studies incorporated in the review investigate several administration modalities, including inhalation, topical application, and aromatherapy massage. Inhalation has consistently been linked to decreased pain perception, enhanced respiratory patterns, and increased mental well-being, underscoring the many advantages of lavender essential oil in holistic care environments.
Prolonged Grief Disorder and Early Onset Depression in Children Basuki, ⁠Shinta Maulydiyah; Prisnidiawati, Ajeng; Karida, Rika Nur; Rasyid, Rezza Dwi Ar; Ridlo, Fairuz; Ilahi, Marintik; Algristian, Hafid
Medicor : Journal of Health Informatics and Health Policy Vol. 3 No. 3 (2025): July 2025
Publisher : Indonesian Scientific Publication

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61978/medicor.v3i3.536

Abstract

Children who experience the death of a significant attachment figure, such as a parent or grandparent, are particularly vulnerable to Prolonged Grief Disorder (PGD) and early-onset depression. Unlike adults, children may manifest grief through somatic symptoms, irritability, or behavioral disturbances rather than overt sadness. The grief process in childhood, if not properly addressed, can disrupt emotional regulation, cognitive development, and psychosocial functioning. This case report discusses a 10-year-old boy who developed depressive symptoms following the loss of his grandfather, with whom he had a strong emotional bond. His symptoms included persistent sadness, social withdrawal, emotional dysregulation, and somatic complaints. These were compounded by environmental stressors such as parental divorce, an emotionally invalidating caregiving environment, and exposure to an aggressive alcoholic family member. Assessment involved clinical interviews, psychiatric evaluations, and a comprehensive review of literature addressing grief and child mental health. The patient met the diagnostic criteria for PGD and showed comorbid early-onset depression, highlighting the interconnected nature of grief and affective disorders in children. Neurobiological factors, particularly dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, were considered in the etiology. The case underscores the importance of early recognition, family-centered psychosocial interventions, and integrative therapeutic approaches including cognitive-behavioral therapy (CBT), expressive arts, and complementary methods such as aromatherapy. This report emphasizes the urgent need for culturally sensitive, trauma-informed strategies to help bereaved children navigate loss and prevent chronic psychiatric outcomes. Early intervention plays a critical role in promoting resilience and long-term mental well-being in grieving children.
Antipsychotic Switching in Bipolar Disorder with Metabolic Comorbidities: A Case Report Syadza, Lailatus; Ahadiah, Hayyunah Rohmatul; Shafly, Moch. Syafirul Nur; Algristian, Hafid; Huda, Miftakhul
Sinergi International Journal of Psychology Vol. 3 No. 3 (2025): August 2025
Publisher : Yayasan Sinergi Kawula Muda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61194/psychology.v3i3.782

Abstract

Bipolar disorder is a chronic psychiatric condition marked by alternating episodes of mania, hypomania, and depression, often with psychotic features. Treatment resistance and adverse metabolic effects from long-term antipsychotic use pose significant challenges. This case report presents a 31-year-old male in Indonesia with bipolar disorder and metabolic comorbidities, including type 2 diabetes mellitus and dyslipidemia. Initially treated with clozapine, the patient experienced metabolic decompensation, prompting an urgent switch to quetiapine. Post-switch, he exhibited improved mood stability and remission of psychotic symptoms, though residual depressive symptoms persisted. Lithium and sertraline were introduced to address these, with careful monitoring. The case highlights the importance of individualized switching strategies in bipolar disorder, particularly in patients with metabolic risks. Antipsychotic selection should consider both psychiatric efficacy and metabolic safety. Despite pharmacological improvement, functional recovery was incomplete, emphasizing the role of psychosocial interventions and culturally informed care. The integration of religious values and family support proved essential in this context. Although effective in symptom stabilization, the switch strategy remains limited by the lack of long-term follow-up and generalizability. This report underscores the need for structured protocols for antipsychotic switching and holistic treatment models, especially in resource-limited settings. Future research should explore integrative approaches that address both psychiatric and physical health dimensions, ensuring continuity of care beyond pharmacological intervention.
The Relationship Between Low Socioeconomic and Depressive Symptoms: A Case Report Ridlo, Fairuz; Rasyid, Rezza Dwi Ar; Karida, Rika Nur; Prisnidiawati, Ajeng; Basuki, Shinta Maulydiyah; Kasiani, Tutik Nur; Algristian, Hafid
Medicor : Journal of Health Informatics and Health Policy Vol. 3 No. 2 (2025): April 2025
Publisher : Indonesian Scientific Publication

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61978/medicor.v3i2.534

Abstract

Depression is a prevalent mental health disorder that significantly impacts both individual well-being and broader societal functioning. Socioeconomic disadvantage manifested through low income, limited educational attainment, and reduced access to mental health care has consistently emerged as a key risk factor for the development and persistence of depressive symptoms. In Indonesia, the mental health burden among low income populations remains under recognized and under treated. This case report details the clinical presentation of a 35-year-old woman diagnosed with major depressive disorder, originating from a low socioeconomic background. The patient experienced chronic psychological distress linked to financial instability, family rejection, and social stigma related to her informal digital employment. Data were collected through comprehensive psychiatric evaluation, including structured interviews, mental status examination, and physical assessment, in accordance with DSM-5 diagnostic criteria. The patient's symptoms marked by insomnia, anhedonia, anxiety, suicidal ideation, and psychosomatic complaints highlight the complex interplay between environmental hardship and mental health. Her case exemplifies how economic precarity and insufficient social support contribute to both emotional and physical deterioration. This report not only contributes to a deeper understanding of depression among socioeconomically marginalized individuals in Indonesia but also emphasizes the importance of culturally contextualized mental health strategies. It advocates for community based, low barrier interventions that incorporate psychosocial and economic dimensions. Ultimately, addressing mental health within low SES populations requires holistic approaches that extend beyond clinical treatment and include policy reforms focused on employment protection, social welfare, and anti-stigma efforts.
A Case Report on Moderate Depression as a Precipitating Factor for Chronic Gastritis Rasyid, Rezza Dwi Ar; Ridlo, Fairuz; Karida, Rika Nur; Prisnidiawati, Ajeng; Basuki, Shinta Maulydiyah; Kasiani, Tutik Nur; Algristian, Hafid
Medicor : Journal of Health Informatics and Health Policy Vol. 3 No. 3 (2025): July 2025
Publisher : Indonesian Scientific Publication

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61978/medicor.v3i3.535

Abstract

Depression is increasingly acknowledged as a key contributor to gastrointestinal dysfunction, primarily through neuroendocrine mechanisms such as activation of the hypothalamic–pituitary–adrenal (HPA) axis. Elevated cortisol in depressive states may trigger increased gastric acid secretion, altered gut motility, and intestinal barrier disruption, which contribute to inflammation and recurrent gastritis. While chronic gastritis is often treated pharmacologically, the psychological dimension is frequently overlooked. This case report investigates the role of moderate depression as a triggering factor for chronic gastritis through HPA axis dysregulation. A 33-year-old woman diagnosed with both conditions was followed for six months. Data were obtained via DSM-5-based psychiatric assessments, medical records, and follow-up interviews. The patient was treated with sertraline (50 mg/day) and standard gastritis therapy. Notable improvements in depressive symptoms were observed, along with a marked reduction in gastritis recurrence. This outcome supports existing evidence that psychological stress can impact gastrointestinal health via neuroinflammatory responses, immune dysfunction, and microbiota alteration. The case highlights the importance of an integrated treatment model that addresses both psychological and physical aspects. Routine mental health screening in patients with persistent gastrointestinal symptoms may enhance treatment efficacy and reduce recurrence. A biopsychosomatic approach involving collaboration between psychiatry and gastroenterology is recommended for comprehensive and effective care.